info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm of other and unspecified endocrine glands (controls excluding all cancers)

CD2_BENIGN_ENDOCRINE_OTH_EXALLC

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D35
Cause of death: ICD-10 D35

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

3544

diagram downward connector
CD2_BENIGN_ENDOCRINE_OTH_EXALLC

Control definitions

Control exclude C3_CANCER

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D10-D36
Name in latin Neoplasmata benigna glandularum endocrinarum aliarum et non specificatarum

Similar endpoints

List of similar endpoints to Benign neoplasm of other and unspecified endocrine glands (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 3544 2111 1433
Unadjusted prevalence (%) 0.94 1.00 0.86
Mean age at first event (years) 56.70 54.45 60.02

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: CD2_BENIGN_ENDOCRINE_OTH_EXALLC – Benign neoplasm of other and unspecified endocrine glands (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Benign neoplasm of other and unspecified endocrine glands (controls excluding all cancers)

Endpoint not on priority list, no data to show.